EXOZ logo

eXoZymes, Inc.

EXOZ
Healthcare|Biotechnology|US
$4.40
+0.29 (+7.06%)
DCF Value
$0.14
Tangible Book / Share
$0.42
Cash / Share
$0.65

Ownership Breakdown

26.7%
Float
9.3M
Shares Outstanding
2.5M
Float Shares

Major Holders (6)

Combined: 153.5%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Christopher A. MarlettIndividual43.61%4,155,904Nov 18, 202413D/G
Anthony DiGiandomenicoIndividual43.61%4,155,904Nov 18, 202413D/G
MDB Capital Holdings, LLCBD, HC43.41%4,136,426Nov 18, 202413D/G
Tyler KormanIndividual8.74%832,569Nov 18, 202413D/G
Paul OpgenorthIndividual7.81%744,333Nov 18, 202413D/G
James U BowieIndividual6.27%597,388Nov 18, 202413D/G

Insider Trades (36)

Last 4 quarters: 479,739 acquired · 1,500 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Perriman Damien AlanChief Commercial OfficerOct 9, 2026OPTION EX.3,922——Form 4
Perriman Damien AlanChief Commercial OfficerOct 9, 2026OPTION EX.3,922——Form 4
Perriman Damien AlanChief Commercial OfficerOct 12, 2026SELL3,729$5.21$19.4KForm 4
Korman Tyler PazofficerAug 19, 2026OTHER0——Form 4
Rayo Edgardo JavierdirectorOct 1, 2026AWARD25,000$6.28$157.0KForm 4
MARLETT CHRISTOPHER Adirector, 10 percent owner: Oct 1, 2026AWARD10,000$6.28$62.8KForm 4
Lalonde James JosephdirectorOct 1, 2026AWARD10,000$6.28$62.8KForm 4
DIGIANDOMENICO ANTHONYdirector, 10 percent owner: Oct 1, 2026AWARD10,000$6.28$62.8KForm 4
Bowie James UlrichdirectorOct 1, 2026AWARD10,000$6.28$62.8KForm 4
BELL LON EdirectorOct 1, 2026AWARD10,000$6.28$62.8KForm 4
Nawaz FouadVice President- FinanceSep 14, 2026AWARD45,000$6.28$282.6KForm 4
Heltzen MichaelChief Executive OfficerAug 26, 2026BUY4$7.58$30.32Form 4
Heltzen MichaelChief Executive OfficerAug 26, 2026BUY251$7.35$1.8KForm 4
Heltzen MichaelChief Executive OfficerAug 26, 2026BUY250$7.60$1.9KForm 4
Heltzen MichaelChief Executive OfficerAug 25, 2026BUY250$7.52$1.9KForm 4
Heltzen MichaelChief Executive OfficerAug 25, 2026BUY100$7.50$750.00Form 4
Heltzen MichaelChief Executive OfficerAug 19, 2026AWARD8,841$6.40$56.6KForm 4
Perriman Damien AlanChief Commercial OfficerAug 19, 2026OPTION EX.19,612——Form 4
Perriman Damien AlanChief Commercial OfficerAug 19, 2026OPTION EX.19,612——Form 4
Korman Tyler PazChief Scientific OfficerAug 19, 2026OPTION EX.32,964——Form 4
Korman Tyler PazChief Scientific OfficerAug 19, 2026OPTION EX.32,964——Form 4
Korman Tyler PazChief Scientific OfficerApr 8, 2026SELL750$10.04$7.5KForm 4
Korman Tyler PazChief Scientific OfficerApr 9, 2026SELL750$10.53$7.9KForm 4
Perriman Damien AlanChief Commercial OfficerApr 1, 2026AWARD146,437$9.49$1.4MForm 4
Perriman Damien AlanChief Commercial OfficerApr 1, 2026AWARD62,759——Form 4
Perriman Damien AlanofficerApr 1, 2026OTHER0——Form 4
Perriman Damien AlanChief Commercial OfficerApr 1, 2026AWARD8,887$8.44$75.0KForm 4
Opgenorth Paul HideoVice President, DevelopmentApr 1, 2026AWARD3,999$8.44$33.8KForm 4
Nawaz FouadVice President- FinanceApr 1, 2026AWARD5,999$8.44$50.6KForm 4
Korman Tyler PazChief Scientific OfficerApr 1, 2026AWARD5,332$8.44$45.0KForm 4
Heltzen MichaelChief Executive OfficerJul 2, 2025BUY1,040$10.22$10.6KForm 4
Heltzen MichaelChief Executive OfficerJun 17, 2025AWARD235,817$12.40$2.9MForm 4
Korman Tyler PazVice President, ResearchJun 16, 2025AWARD2,990$12.54$37.5KForm 4
Opgenorth Paul HideoVice President, DevelopmentJun 13, 2025AWARD2,990$12.54$37.5KForm 4
Nawaz FouadVice President, FinanceJun 13, 2025AWARD3,489$12.54$43.8KForm 4
Rayo Edgardo JavierdirectorFeb 17, 2025OTHER0——Form 4